Ondansetron, a 5-HT3 receptor antagonist, partially attenuates the effects of amphetamine: a pilot study in healthy volunteers.
Preclinical studies suggest that 5-HT3 antagonists modulate dopamine-mediated responses in the limbic system and may therefore have a therapeutic role in psychiatry. We have examined the effect of ondansetron, a specific 5-HT3 antagonist, on the psychological and psychomotor changes induced by amphe...
Main Authors: | Silverstone, P, Oldman, D, Johnson, B, Cowen, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1992
|
Similar Items
-
Does ondansetron attenuate amphetamine-induced behaviour in human volunteers?
by: Silverstone, P, et al.
Published: (1992) -
ONDANSETRON ATTENUATES THE PSYCHOLOGICAL, BUT NOT THE PSYCHOMOTOR EFFECTS OF AMPHETAMINE
by: Silverstone, P, et al.
Published: (1992) -
The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.
by: Silverstone, P, et al.
Published: (1994) -
Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor.
by: Rice, G, et al.
Published: (1997) -
Attenuation of some alcohol-induced mood changes and the desire to drink by 5-HT3 receptor blockade: a preliminary study in healthy male volunteers.
by: Johnson, B, et al.
Published: (1993)